カテゴリ： 世界, 環境/エネルギー, QYResearch

ギランバレー症候群治療の世界市場2023年：免疫グロブリン療法、血漿交換療法（プラズマフェレーシス）

■ 英語タイトル：Global Guillain-Barre Syndrome Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7475）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7475
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：89
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ギランバレー症候群治療の世界市場2023年：免疫グロブリン療法、血漿交換療法（プラズマフェレーシス）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はギランバレー症候群治療のグローバル市場について調査・分析し、世界のギランバレー症候群治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（免疫グロブリン療法、血漿交換療法（プラズマフェレーシス））、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、CSL Limited、Grifols S A、Octapharma AG、Kedrion Biopharma Inc、Biotest AGなどが含まれています。ギランバレー症候群治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ギランバレー症候群治療市場規模を算出する際に考慮しました。

・ギランバレー症候群治療市場の概要
- ギランバレー症候群治療の種類別セグメント
- 世界のギランバレー症候群治療市場規模：タイプ別分析（免疫グロブリン療法、血漿交換療法（プラズマフェレーシス））
- ギランバレー症候群治療の用途別セグメント
- 世界のギランバレー症候群治療市場規模：用途別分析（病院、クリニック、その他）
- 世界のギランバレー症候群治療市場規模予測（2018年-2029年）

・ギランバレー症候群治療市場の成長トレンド
- ギランバレー症候群治療の地域別市場規模（2018年-2029年）
- ギランバレー症候群治療市場ダイナミクス
- ギランバレー症候群治療の業界動向
- ギランバレー症候群治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：免疫グロブリン療法、血漿交換療法（プラズマフェレーシス）
- 世界のギランバレー症候群治療のタイプ別市場規模（2018年-2023年）
- 世界のギランバレー症候群治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、クリニック、その他
- 世界のギランバレー症候群治療の用途別市場規模（2018年-2023年）
- 世界のギランバレー症候群治療の用途別市場規模（2024年-2029年）

・ギランバレー症候群治療の地域別市場規模
- 北米のギランバレー症候群治療市場規模（2018年-2029年）
- 米国のギランバレー症候群治療市場規模（2018年-2029年）
- ヨーロッパのギランバレー症候群治療市場規模（2018年-2029年）
- アジア太平洋のギランバレー症候群治療市場規模（2018年-2029年）
- 中国のギランバレー症候群治療市場規模（2018年-2029年）
- 日本のギランバレー症候群治療市場規模（2018年-2029年）
- 韓国のギランバレー症候群治療市場規模（2018年-2029年）
- インドのギランバレー症候群治療市場規模（2018年-2029年）
- オーストラリアのギランバレー症候群治療市場規模（2018年-2029年）
- 中南米のギランバレー症候群治療市場規模（2018年-2029年）
- 中東・アフリカのギランバレー症候群治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
CSL Limited、Grifols S A、Octapharma AG、Kedrion Biopharma Inc、Biotest AG

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Guillain-Barre Syndrome Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Guillain-Barre Syndrome Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Guillain-Barre Syndrome Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Guillain-Barre Syndrome Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Guillain-Barre Syndrome Treatment include CSL Limited, Grifols S A, Octapharma AG, Kedrion Biopharma Inc and Biotest AG, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Guillain-Barre Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Guillain-Barre Syndrome Treatment.
The Guillain-Barre Syndrome Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Guillain-Barre Syndrome Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Guillain-Barre Syndrome Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
CSL Limited
Grifols S A
Octapharma AG
Kedrion Biopharma Inc
Biotest AG
Segment by Type
Immunoglobulin Therapy
Plasma Exchange (Plasmapheresis)
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Guillain-Barre Syndrome Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Guillain-Barre Syndrome Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Immunoglobulin Therapy
1.2.3 Plasma Exchange (Plasmapheresis)
1.3 Market by Application
1.3.1 Global Guillain-Barre Syndrome Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Guillain-Barre Syndrome Treatment Market Perspective (2018-2029)
2.2 Guillain-Barre Syndrome Treatment Growth Trends by Region
2.2.1 Global Guillain-Barre Syndrome Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Guillain-Barre Syndrome Treatment Historic Market Size by Region (2018-2023)
2.2.3 Guillain-Barre Syndrome Treatment Forecasted Market Size by Region (2024-2029)
2.3 Guillain-Barre Syndrome Treatment Market Dynamics
2.3.1 Guillain-Barre Syndrome Treatment Industry Trends
2.3.2 Guillain-Barre Syndrome Treatment Market Drivers
2.3.3 Guillain-Barre Syndrome Treatment Market Challenges
2.3.4 Guillain-Barre Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Guillain-Barre Syndrome Treatment Players by Revenue
3.1.1 Global Top Guillain-Barre Syndrome Treatment Players by Revenue (2018-2023)
3.1.2 Global Guillain-Barre Syndrome Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Guillain-Barre Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Guillain-Barre Syndrome Treatment Revenue
3.4 Global Guillain-Barre Syndrome Treatment Market Concentration Ratio
3.4.1 Global Guillain-Barre Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Guillain-Barre Syndrome Treatment Revenue in 2022
3.5 Guillain-Barre Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Guillain-Barre Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Guillain-Barre Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Guillain-Barre Syndrome Treatment Breakdown Data by Type
4.1 Global Guillain-Barre Syndrome Treatment Historic Market Size by Type (2018-2023)
4.2 Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Type (2024-2029)
5 Guillain-Barre Syndrome Treatment Breakdown Data by Application
5.1 Global Guillain-Barre Syndrome Treatment Historic Market Size by Application (2018-2023)
5.2 Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Guillain-Barre Syndrome Treatment Market Size (2018-2029)
6.2 North America Guillain-Barre Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023)
6.4 North America Guillain-Barre Syndrome Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Guillain-Barre Syndrome Treatment Market Size (2018-2029)
7.2 Europe Guillain-Barre Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023)
7.4 Europe Guillain-Barre Syndrome Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size (2018-2029)
8.2 Asia-Pacific Guillain-Barre Syndrome Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Guillain-Barre Syndrome Treatment Market Size (2018-2029)
9.2 Latin America Guillain-Barre Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023)
9.4 Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size (2018-2029)
10.2 Middle East & Africa Guillain-Barre Syndrome Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CSL Limited
11.1.1 CSL Limited Company Detail
11.1.2 CSL Limited Business Overview
11.1.3 CSL Limited Guillain-Barre Syndrome Treatment Introduction
11.1.4 CSL Limited Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.1.5 CSL Limited Recent Development
11.2 Grifols S A
11.2.1 Grifols S A Company Detail
11.2.2 Grifols S A Business Overview
11.2.3 Grifols S A Guillain-Barre Syndrome Treatment Introduction
11.2.4 Grifols S A Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.2.5 Grifols S A Recent Development
11.3 Octapharma AG
11.3.1 Octapharma AG Company Detail
11.3.2 Octapharma AG Business Overview
11.3.3 Octapharma AG Guillain-Barre Syndrome Treatment Introduction
11.3.4 Octapharma AG Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.3.5 Octapharma AG Recent Development
11.4 Kedrion Biopharma Inc
11.4.1 Kedrion Biopharma Inc Company Detail
11.4.2 Kedrion Biopharma Inc Business Overview
11.4.3 Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Introduction
11.4.4 Kedrion Biopharma Inc Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.4.5 Kedrion Biopharma Inc Recent Development
11.5 Biotest AG
11.5.1 Biotest AG Company Detail
11.5.2 Biotest AG Business Overview
11.5.3 Biotest AG Guillain-Barre Syndrome Treatment Introduction
11.5.4 Biotest AG Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023)
11.5.5 Biotest AG Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Guillain-Barre Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Immunoglobulin Therapy
Table 3. Key Players of Plasma Exchange (Plasmapheresis)
Table 4. Global Guillain-Barre Syndrome Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Guillain-Barre Syndrome Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Guillain-Barre Syndrome Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Guillain-Barre Syndrome Treatment Market Share by Region (2018-2023)
Table 8. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Guillain-Barre Syndrome Treatment Market Share by Region (2024-2029)
Table 10. Guillain-Barre Syndrome Treatment Market Trends
Table 11. Guillain-Barre Syndrome Treatment Market Drivers
Table 12. Guillain-Barre Syndrome Treatment Market Challenges
Table 13. Guillain-Barre Syndrome Treatment Market Restraints
Table 14. Global Guillain-Barre Syndrome Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Guillain-Barre Syndrome Treatment Market Share by Players (2018-2023)
Table 16. Global Top Guillain-Barre Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guillain-Barre Syndrome Treatment as of 2022)
Table 17. Ranking of Global Top Guillain-Barre Syndrome Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Guillain-Barre Syndrome Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Guillain-Barre Syndrome Treatment Product Solution and Service
Table 21. Date of Enter into Guillain-Barre Syndrome Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Guillain-Barre Syndrome Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Guillain-Barre Syndrome Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Guillain-Barre Syndrome Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Guillain-Barre Syndrome Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Guillain-Barre Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Guillain-Barre Syndrome Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Guillain-Barre Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Guillain-Barre Syndrome Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Guillain-Barre Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Guillain-Barre Syndrome Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. CSL Limited Company Detail
Table 47. CSL Limited Business Overview
Table 48. CSL Limited Guillain-Barre Syndrome Treatment Product
Table 49. CSL Limited Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 50. CSL Limited Recent Development
Table 51. Grifols S A Company Detail
Table 52. Grifols S A Business Overview
Table 53. Grifols S A Guillain-Barre Syndrome Treatment Product
Table 54. Grifols S A Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 55. Grifols S A Recent Development
Table 56. Octapharma AG Company Detail
Table 57. Octapharma AG Business Overview
Table 58. Octapharma AG Guillain-Barre Syndrome Treatment Product
Table 59. Octapharma AG Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 60. Octapharma AG Recent Development
Table 61. Kedrion Biopharma Inc Company Detail
Table 62. Kedrion Biopharma Inc Business Overview
Table 63. Kedrion Biopharma Inc Guillain-Barre Syndrome Treatment Product
Table 64. Kedrion Biopharma Inc Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 65. Kedrion Biopharma Inc Recent Development
Table 66. Biotest AG Company Detail
Table 67. Biotest AG Business Overview
Table 68. Biotest AG Guillain-Barre Syndrome Treatment Product
Table 69. Biotest AG Revenue in Guillain-Barre Syndrome Treatment Business (2018-2023) & (US$ Million)
Table 70. Biotest AG Recent Development
Table 71. Research Programs/Design for This Report
Table 72. Key Data Information from Secondary Sources
Table 73. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Guillain-Barre Syndrome Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Guillain-Barre Syndrome Treatment Market Share by Type: 2022 VS 2029
Figure 3. Immunoglobulin Therapy Features
Figure 4. Plasma Exchange (Plasmapheresis) Features
Figure 5. Global Guillain-Barre Syndrome Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Guillain-Barre Syndrome Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Guillain-Barre Syndrome Treatment Report Years Considered
Figure 11. Global Guillain-Barre Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Guillain-Barre Syndrome Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Guillain-Barre Syndrome Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Guillain-Barre Syndrome Treatment Market Share by Players in 2022
Figure 15. Global Top Guillain-Barre Syndrome Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guillain-Barre Syndrome Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Guillain-Barre Syndrome Treatment Revenue in 2022
Figure 17. North America Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Guillain-Barre Syndrome Treatment Market Share by Country (2018-2029)
Figure 19. United States Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Guillain-Barre Syndrome Treatment Market Share by Country (2018-2029)
Figure 23. Germany Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Guillain-Barre Syndrome Treatment Market Share by Region (2018-2029)
Figure 31. China Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Guillain-Barre Syndrome Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Guillain-Barre Syndrome Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Guillain-Barre Syndrome Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. CSL Limited Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 46. Grifols S A Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 47. Octapharma AG Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 48. Kedrion Biopharma Inc Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 49. Biotest AG Revenue Growth Rate in Guillain-Barre Syndrome Treatment Business (2018-2023)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 注意欠陥・多動性症候群治療の世界市場2023年：精神刺激薬、非精神刺激薬
  • ネザートン症候群治療のグローバル市場展望 2023年-2029年：放射線治療、生物治療、その他
  • 進行性運動失調無力症治療のグローバル市場展望 2023年-2029年：タンパク質ミスフォールディング、幹細胞治療
  • 月経前症候群治療薬のグローバル市場展望 2023年-2029年：PH-80PMD、エストロゲン、プロゲステロン、その他
  • 過敏性腸症候群治療薬のグローバル市場展望 2023年-2029年：便秘型過敏性腸症候群、下痢型過敏性腸症候群、便秘・下痢型過敏性腸症候群
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7475 )"ギランバレー症候群治療の世界市場2023年：免疫グロブリン療法、血漿交換療法（プラズマフェレーシス）" (英文：Global Guillain-Barre Syndrome Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。